{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:59:45Z","timestamp":1792011585317,"version":"4.4.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T00:00:00Z","timestamp":1395705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2415-14-36","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T00:02:30Z","timestamp":1395792150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Combined treatment for Coats\u2019 disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases"],"prefix":"10.1186","volume":"14","author":[{"given":"Aya","family":"Kodama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sugioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chota","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,25]]},"reference":[{"key":"413_CR1","first-page":"440","volume":"17","author":"G Coats","year":"1908","unstructured":"Coats G: Forms of retinal dysplasia with massive exudation. R Lond Ophthalmol Hosp Rep. 1908, 17: 440-","journal-title":"R Lond Ophthalmol Hosp Rep"},{"issue":"131","key":"413_CR2","first-page":"572","volume":"2001","author":"JA Shields","year":"2000","unstructured":"Shields JA, Shields CL, Honavar SG, Demirci H, Cater J: Classification and management of coats disease: the 2000 proctor lecture. Am J Ophthalmol. 2000, 2001 (131): 572-583.","journal-title":"Am J Ophthalmol"},{"key":"413_CR3","volume-title":"Graefes Arch Clin Exp Ophthalmol","author":"D Suesskind","year":"2013","unstructured":"Suesskind D, Altpeter E, Schrader M, Bartz-Schmidt KU, Aisenbrey S: Pars plana vitrectomy for treatment of advanced Coats\u2019 diseasepresentation of a modified surgical technique and long-term follow-up. Graefes Arch Clin Exp Ophthalmol. 2013, in press"},{"issue":"9","key":"413_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00417-007-0559-8","volume":"245","author":"Y Sun","year":"2007","unstructured":"Sun Y, Jain A, Moshfeghi DM: Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium. Graefes Arch Clin Exp Ophthalmol. 2007, 245 (9): 1387-1388. 10.1007\/s00417-007-0559-8.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"413_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00417-010-1366-1","volume":"248","author":"YG He","year":"2010","unstructured":"He YG, Wang H, Zhao B, Lee J, Bahl D, McClusky J: Elevated vascular endothelial growth factor level in Coats\u2019 disease and possible therapewtic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol. 2010, 248 (10): 1519-1521. 10.1007\/s00417-010-1366-1.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"413_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.survophthal.2013.03.007","volume":"59","author":"EJ Sigler","year":"2014","unstructured":"Sigler EJ, Randolph JC, Calzada JI, Wilson MW, Haik BG: Current management of Coats disease. Surv Ophthalmol. 2014, 59 (1): 30-46. 10.1016\/j.survophthal.2013.03.007.","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"413_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1136\/bjophthalmol-2012-302250","volume":"97","author":"R Ray","year":"2013","unstructured":"Ray R, Baranano DE, Hubbard GB: Treatment of Coats\u2019 disease with intravitreal bevacizumab. Br J Ophthalmol. 2013, 97 (3): 272-277. 10.1136\/bjophthalmol-2012-302250.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"413_CR8","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1755-3768.2008.01253.x","volume":"87","author":"PK Stergiou","year":"2009","unstructured":"Stergiou PK, Symeonidis C, Dimitrakos SA: Coats\u2019 disease: treatment with intravitreal bevacizumab and laser photocoagulation. Acta Ophthalmol. 2009, 87 (6): 687-688. 10.1111\/j.1755-3768.2008.01253.x.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"413_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00417-013-2409-1","volume":"252","author":"XX Zheng","year":"2014","unstructured":"Zheng XX, Jiang YR: The effect of intravitreal bevacizumab injection as initial treatment for Coats\u2019 disease. Graefes Arch Clin Exp Ophthalmol. 2014, 252 (1): 35-42. 10.1007\/s00417-013-2409-1.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"413_CR10","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/IAE.0b013e3181c2e0b7","volume":"30","author":"CJ Lin","year":"2010","unstructured":"Lin CJ, Hwang JF, Chen YT, Chen SN: The effect of intravitreal bevacizumab in the treatment of Coats disease in children. Retina. 2010, 30 (4): 617-622. 10.1097\/IAE.0b013e3181c2e0b7.","journal-title":"Retina"},{"issue":"4","key":"413_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1159\/000336906","volume":"227","author":"S Ghorbanian","year":"2012","unstructured":"Ghorbanian S, Jaulim A, Chatziralli IP: Diagnosis and Coats\u2019 disease: a review of the literature. Ophthalmologica. 2012, 227 (4): 175-182. 10.1159\/000336906.","journal-title":"Ophthalmologica"},{"issue":"12","key":"413_CR12","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/eye.2010.126","volume":"24","author":"B Morris","year":"2010","unstructured":"Morris B, Foot B, Mulvihill A: A population-based study of Coats disease in the United Kingdom: epidemiology and clinical features at diagnosis. Eye. 2010, 24 (12): 1797-1801. 10.1038\/eye.2010.126.","journal-title":"Eye"},{"issue":"3","key":"413_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/bjophthalmol-2011-300141","volume":"96","author":"A Ramasubramanian","year":"2012","unstructured":"Ramasubramanian A, Shields CL: Bevacizumab for Coats\u2019 disease with exudative retinal detachment and risk of vitreoretinal traction. Br J Ophthalmol. 2012, 96 (3): 356-359. 10.1136\/bjophthalmol-2011-300141.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"413_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/bjophthalmol-2011-301418","volume":"97","author":"S Ito","year":"2013","unstructured":"Ito S, Miyamoto N, Ishida K, Kurimoto Y: Association between external limiting membrane status and visual acuity in diabetic macular oedema. Br J Ophthalmol. 2013, 97 (2): 228-232. 10.1136\/bjophthalmol-2011-301418.","journal-title":"Br J Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-36.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-14-36\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-36","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-36.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:23:29Z","timestamp":1630553009000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-14-36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,25]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["413"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-14-36","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,25]]},"assertion":[{"value":"12 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"36"}}